Adenosine A2A receptor antagonists have shown great promise in the
treatment of Parkinson's Disease and alleviation of symptoms. This
book addresses various aspects of this class of drugs from their
chemical development to their clinical use. Among the many
insightful chapters contained in this book, there are three unique
reviews that have not previously been published in any format: (1)
a history of istradefylline, the first A2A antagonist approved for
treatment of Parkinson's Disease, (2) an overview of neuroimaging
studies in human death and disease and (3) a study of urate as a
possible biomarker and neuroprotectant.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!